Advertisement

Boston biotech Spencer Pharmaceutical Inc. (PINKSHEETS: SPPH) has signed an agreement with Polyvalor LP, the commercial partner of Ecole Polytechnique de Montreal, to further develop the technologies protected by two patent applications developed by professor Michael Buschmann and co-workers at the Montreal engineering college.

Polyvalor is managed by Gestion Univalor LP, which is a technology transfer arm of the Universite de Montreal.

SOURCE

Advertisement
Advertisement